Ajaikumar B Kunnumakkara

26PUBLICATIONS
35CO-AUTHORS
Predictive and prognostic markersNanomedicineNanomaterialsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Mar 28, 2026
HOXA9 orchestrates EMT and metastasis in oral cancer via transcriptional activation of vimentin and β-catenin signaling.

U Sangeetha Shenoy, Divya Adiga, Dhanraj Salur Basavarajappa

|Feb 24, 2026
Correction: Harnessing nanomedicine to target NFκB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.

Bandari BharathwajChetty, Babu Santha Aswani, Shweta S Shinde

|Jan 06, 2026
Harnessing nanomedicine to target NF-κB signalling in cancer: at the intersection of inflammatory signalling, metabolic reprogramming, and therapeutic innovation.

Bandari BharathwajChetty, Babu Santha Aswani, Shweta S Shinde

|Nov 10, 2025
Suppression of NGALR impedes TNBC cell survival, proliferation, invasion, and migration through Akt/mTOR and JAK/STAT3 pathway inhibition.

Krishan Kumar Thakur, Choudhary Harsha, Bethsebie L Sailo

|Oct 27, 2025
Enhancing Anticancer Treatment Efficacy With Lycopene: A Comprehensive Review of Clinical and Preclinical Evidence.

Ravichandran Vishwa, Bethsebie Lalduhsaki Sailo, Bandari BharathwajChetty

|Oct 18, 2025
A novel soil Bacillus strain GB_SG_008: isolation, characterization, and anticancer potential of an intracellular protein fraction inducing apoptosis and modulating cancer marker proteins.

Gourav Bhattacharjee, Sosmitha Girisa, Ajaikumar B Kunnumakkara

Pageof 5

Frequent Collaborators

6 joint publications

Gautam Sethi

3 joint publications

Bandari BharathwajChetty

3 joint publications

Dey Parama

3 joint publications

Anupam Bishayee